THERAPEUTIC AGENT FOR DYSLIPIDEMIA

The present invention addresses the problem of providing a pharmaceutical combination composition and drug combinations for the prevention and/or treatment of dyslipidemic conditions such as atherosclerosis, hypercholesterolemia, low HDL blood disease in mammals including humans. A pharmaceutical co...

Full description

Saved in:
Bibliographic Details
Main Authors Yasunobu YOSHINAKA, Toshiaki TAKIZAWA
Format Patent
LanguageEnglish
Published 23.09.2020
Online AccessGet full text

Cover

More Information
Summary:The present invention addresses the problem of providing a pharmaceutical combination composition and drug combinations for the prevention and/or treatment of dyslipidemic conditions such as atherosclerosis, hypercholesterolemia, low HDL blood disease in mammals including humans. A pharmaceutical composition for the prevention and/or treatment of dyslipidemia, etc. which comprises (a) a compound represented by the general formula (1) (in the formula, each symbol is the same as defined in the specification) or a salt thereof or a solvate thereof and (b) a cholesterol absorption inhibitor.
Bibliography:Application Number: MY2015PI700727